Fennec Pharmaceuticals Inc trades with the ticker FRX on the TSX and is in the Biotechnology industry.
Overview
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. The company’s product candidates include PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity hearing loss in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.
Looking to invest in Fennec Pharmaceuticals Inc? Our analysis brings in the key facts, competitor research and valuation metrics for you to make an informed decision.
Table of Contents
show
FRX.TO Stock Price and Key Stats
ETF Key Stats
Exchange: TSX
Market Cap : $352.565MM
PE Ratio:
Price: 13.2 (Updated: 3/12/2024 0:47:16)
Fennec Pharmaceuticals Inc (FRX) vs Competitors in Biotechnology
Lets see how FRX.TO stacks up against others in the Biotechnology asset management industry. We have identified its main peers as:Aeterna Zentaris Inc, Aptose Biosciences Inc, BELLUS Health Inc, IMV Inc, Intellipharmaceutics International Inc
.Biotechnology Industry Comparisons
| Company | Market Cap ($MM) | P/E Ratio | EV/EBITDA | Dividend Yield |
|---|---|---|---|---|
| Aeterna Zentaris Inc (AEZS) | $12.674 | N/A | 1.709 | N/A% |
| Aptose Biosciences Inc (APS) | $33.927 | N/A | -0.231 | N/A% |
| BELLUS Health Inc (BLU) | $2,470.298 | N/A | -16.428 | 0.0% |
| Fennec Pharmaceuticals Inc (FRX) | $352.565 | N/A | -21.793 | N/A% |
| IMV Inc (IMV) | $13.117 | N/A | -0.843 | 0.0% |
EV/EBITDA: Enterprise Value to Earnings Before Interest, Taxes, Depreciation, and Amortization – this ratio compares the value of a company, including debt, to the company’s cash earnings less non-cash expenses
Industry: companies that have a lot in common
Market Cap: Market Capitalization – the total value of all a corporation’s stock
N/A: Not Applicable or Not Available
P/E: Price-to-Earnings – this ratio relates a corporation’s share price to its earnings per share
Price: Stock Price – current value to buyers and sellers
Dividend Yield: Dividend or Distribution Yield
Comparisons within Biotechnology
- Fennec Pharmaceuticals Inc (FRX) vs Aeterna Zentaris Inc (AEZS)
- FRX has higher EPS (-1.01 vs -6.47). AEZS and FRX both have P/E’s under 0.
- Fennec Pharmaceuticals Inc (FRX) vs Aptose Biosciences Inc (APS)
- FRX has higher EPS (-1.01 vs -10.45). APS and FRX both have P/E’s under 0.
- Fennec Pharmaceuticals Inc (FRX) vs BELLUS Health Inc (BLU)
- BLU has higher EPS (-0.96 vs -1.01). BLU provides dividends, while FRX does not. BLU and FRX both have P/E’s under 0.
- Fennec Pharmaceuticals Inc (FRX) vs IMV Inc (IMV)
- FRX has higher EPS (-1.01 vs -6.11). IMV provides dividends, while FRX does not. IMV and FRX both have P/E’s under 0.
- Fennec Pharmaceuticals Inc (FRX) vs Intellipharmaceutics International Inc (IPCI)
- IPCI has higher EPS (-0.12 vs -1.01). IPCI and FRX both have P/E’s under 0.
Our Recommendation: Hold
Features a lower EV/EBITDA ratio (-21.79) than the industry average (-4.03), indicating attractive valuation.
How to Buy FRX stock on the TSX
You can buy on pretty much any online brokerage in Canada, since it trades on the TSX. If you are looking for some easy options take a look at these two:| Image | Product Title | Features | Price |
|---|---|---|---|
Editor's Choice  |
| Get $25 Signup Bonus | |
Reliable Pick  |
| Get $50 Free Stock Trades |
